Abstract
Non-steroid anti-inflammatory drugs (NSAIDs) exert their beneficial anti-inflammatory actions, as well as their undesirable gastro-intestinal effects, through inhibition of the enzyme prostaglandin H synthase1, also referred to as cyclooxygenase (COX). The discovery of an inducible COX enzyme (COX-2), distinct from the constitutively expressed enzyme (COX-1)2,3, has led to the suggestion that a new generation of safer NSAIDs may be developed in the near future. Classical NSAIDs, such as aspirin, flurbiprofen and naproxen, inhibit both COX-1 and COX-2 and are therefore nonselective inhibitors. Simply stated, the COX-2 hypothesis suggests that inhibitors selective for COX-2 over COX-1 should be relatively safer therapeutic agents than currently available NSAIDs. In vivo experiments with selective COX-2 inhibitors support the suggestion that such compounds will have an anti-inflammatory effect without severe gastrointestinal toxicity4.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Vane JR. Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs. Nature New Biol. 1971;231:232–5.
Hla T, Neilson K. Human cyclooxygenase-2 cDNA. Proc Natl Acad Sci. USA. 1992;89:7384–8.
Kujubu DA, Fletcher BS, Varnum BC, Lim RW, Herschman HR. TIS10, a phorbol ester tumor promoter-inducible mRNA from swiss 3T3 cells, encodes a novel prostaglandin synthase/ cyclooxygenase. J Biol Chem. 1991;266:12866–72.
Masferrer JL, Zweifel BS, Manning PT, et al. Selective inhibition of inducible cyclooxygenase 2 in vivo is antiinflammatory and nonulcerogenic. Proc Natl Acad Sci USA. 1994;91:3228–32.
Luong C, Miller A, Barnett J, Chow J, Ramesha C, Browner MF. Flexibility of the NSAID binding site in the structure of human cyclooxygenase-2. Nature Struct Biol. 1996; (in press).
Picot D, Loll PJ, Garavito RM. The X-ray crystal structure of the membrane protein prostaglandin H2 synthase-1. Nature. 1994;367:243–9.
Bamett J, Chow J, Ives D, et al. Purification, characterization and selective inhibition of human prostaglandin G/H synthase 1 and 2 expressed in the baculovirus system. Biochem Biophys Acta. 1994;1209:130–9.
Garavito RM. Crystallizing membrane proteins: Experiments on different systems. In: Michel H, ed. Crystallization of Membrane Proteins. CRC Press, Boca Raton. 1991:89–105.
Abola EE, Berstein FC, Bryant SH, Koetzle TF, Weng J. Protein Data Bank. In: Allen FH, Bergerhoff G, Sievers R, ed. Crystallographic Databases - Information Content, Software Systems, Scientific Applications. Bonn: Data Commission of the International Union of Crystallography, 1987:107–32.
Loll PJ, Picot D, Ekabo O, Garavito RM. Synthesis and use of iodinated nonsteroidal anti-inflammatory drug analogs as crystallographic probes of the prostaglandin Н2 cyclooxygenase active site. Biochemistry. 1996;35:7330–40.
Loll PJ, Picot D, Garavito RM. The structural basis of aspirin activity inferred from the crystal structure of inactivated prostaglandin H2 synthase. Nature Struct Biol. 1995;2:637–42.
Tazawa R, Xu XM, Wu KK, Wang LH. Characterization of the genomic structure, chromosomal location and promoter of human prostaglandin H synthase-2 gene. Biochem Biophys Res Commun. 1994;203:190–9.
Mancini JA, O’Neill GP, Bayly C, Vickers PJ. Mutation of serine-516 in human prostaglandin G/H synthase-2 to methionine and aspirin acetylation of this residue stimulates 15-R-HETE synthesis. FEBS Lett. 1994;342:33–7.
Laneuville O, Breuer DK, Xu N, et al. Fatty acid substrate specificities of human prostaglandinendoperoxide H synthase-1 and -2. J Biol Chem. 1995;270:19330–6.
Laneuville O, Breuer DK, DeWitt DL, Hla T, Funk CD, Smith WL. Differential inhibition of human prostaglandin endoperoxide H synthases-1 and -2 by nonsteroidal anti-inflammatory drugs. J Pharm Exp Ther. 1994;271:927–34.
Garavito RM, Picot D, Loll PJ. The 3.1 Å X-ray crystal structure of the integral membrane enzyme prostaglandin H2 synthase-1. Adv Prostaglandin Thromboxane Leukotriene Res. 1995;23:99–103.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1996 Springer Science+Business Media Dordrecht
About this chapter
Cite this chapter
Browner, M.F. (1996). X-ray crystal structure of human cyclooxygenase-2. In: Bazan, N., Botting, J., Vane, J. (eds) New Targets in Inflammation. Springer, Dordrecht. https://doi.org/10.1007/978-94-011-5386-7_8
Download citation
DOI: https://doi.org/10.1007/978-94-011-5386-7_8
Publisher Name: Springer, Dordrecht
Print ISBN: 978-94-010-6265-7
Online ISBN: 978-94-011-5386-7
eBook Packages: Springer Book Archive